Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell Lymphoma
about
Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell Lymphoma
description
clinical trial
@en
klinisch onderzoek
@nl
name
Rituximab, Bendamustine Hydroc ...... ith Aggressive B-Cell Lymphoma
@en
type
label
Rituximab, Bendamustine Hydroc ...... ith Aggressive B-Cell Lymphoma
@en
prefLabel
Rituximab, Bendamustine Hydroc ...... ith Aggressive B-Cell Lymphoma
@en
P4844
P1050
P1476
Rituximab, Bendamustine and Le ...... d Therapy. A Phase I/II Trial.
@en
P17
P248
P3098
NCT00987493
P580
2009-09-01T00:00:00Z
P582
2014-04-01T00:00:00Z